ConductScience.org, home

Paper26760424

Chemotherapy for resistant or recurrent gestational trophoblastic neoplasia.

Alazzam M and 5 others. Cochrane Database Syst Rev, 2016. Cited by 67 papers, by iCite.

Cite this record

ConductScience Library. Chemotherapy for resistant or recurrent gestational trophoblastic neoplasia. Papers, record 26760424. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/26760424

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Chemotherapy for resistant or recurrent gestational trophoblastic neoplasia.
PubMed
Journal
Cochrane Database Syst Rev
PubMed
Year
2016
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Systematic Review
PubMed
Citations, by iCite
67
iCite
Relative citation ratio, by iCite
3.17
iCite
Revised in PubMed
2025-06-26
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Alazzam MMo'iad
2Tidy JJohn
3Osborne RRaymond
4Coleman RRobert
5Hancock BWBarry W
6Lawrie TATheresa A

Source PubMed

Download CSV of authors

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Drug Resistance, NeoplasmMajor topic
Gestational Trophoblastic DiseaseMajor topic
Neoplasm Recurrence, LocalMajor topic
Female
Humans
Pregnancy

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Update of23235667Chemotherapy for resistant or recurrent gestational trophoblastic neoplasia.https://conductscience.org/library/papers/23235667

Source PubMed

Download CSV of comments and corrections

References55

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
17856688Single-agent methotrexate chemotherapy for the treatment of nonmetastatic gestational trophoblastic tumors.Am J Obstet Gynecol1995https://conductscience.org/library/papers/7856688PubMed
217711444EMA-CO chemotherapy for high-risk gestational trophoblastic neoplasia: a clinical analysis of 54 patients.Int J Gynecol Cancer2008https://conductscience.org/library/papers/17711444PubMed
311240657
Workshop Report: Combining the staging system of the International Federation of Gynecology and Obstetrics with the scoring system of the World Heath Organization for Trophoblastic Neoplasia. Report of the Working Committee of the International Society for the Study of Trophoblastic Disease and the International Gynecologic Cancer Society.
Int J Gynecol Cancer2000https://conductscience.org/library/papers/11240657PubMed
48035370Advances in the epidemiology of gestational trophoblastic disease.J Reprod Med1994https://conductscience.org/library/papers/8035370PubMed
52551474Treatment of high-risk gestational trophoblastic disease with chemotherapy combinations containing cisplatin and etoposide.Cancer1989https://conductscience.org/library/papers/2551474PubMed
619269684Impact of the revised FIGO/WHO system on the management of patients with gestational trophoblastic neoplasia.Gynecol Oncol2009https://conductscience.org/library/papers/19269684PubMed
712065144FIGO staging for gestational trophoblastic neoplasia 2000. FIGO Oncology Committee.Int J Gynaecol Obstet2002https://conductscience.org/library/papers/12065144PubMed
87705678Etoposide-platin combination therapy for chemorefractory gestational trophoblastic disease.Gynecol Oncol1995https://conductscience.org/library/papers/7705678PubMed
915283051EMA/EP chemotherapy for chemorefractory gestational trophoblastic tumor.J Reprod Med2004https://conductscience.org/library/papers/15283051PubMed
1020626175Management of metastatic high-risk gestational trophoblastic neoplasia: FIGO stages II-IV: risk factor score > or = 7.J Reprod Med2010https://conductscience.org/library/papers/20626175PubMed
1119370618Combination chemotherapy for high-risk gestational trophoblastic tumour.Cochrane Database Syst Rev2009https://conductscience.org/library/papers/19370618PubMed
1221263100Phase III trial of weekly methotrexate or pulsed dactinomycin for low-risk gestational trophoblastic neoplasia: a gynecologic oncology group study.J Clin Oncol2011https://conductscience.org/library/papers/21263100PubMed
139826467Risk factors for the prediction of treatment failure in gestational trophoblastic tumors treated with EMA/CO regimen.Gynecol Oncol1998https://conductscience.org/library/papers/9826467PubMed
1417481633Relapsed or refractory gestational trophoblastic neoplasia treated with the etoposide and cisplatin/etoposide, methotrexate, and actinomycin D (EP-EMA) regimen.Int J Gynaecol Obstet2007https://conductscience.org/library/papers/17481633PubMed
1511843379Risk of partial and complete hydatidiform molar pregnancy in relation to maternal age.BJOG2002https://conductscience.org/library/papers/11843379PubMed
163802833Meta-analysis in clinical trials.Control Clin Trials1986https://conductscience.org/library/papers/3802833PubMed
1712209690Salvage combination chemotherapy with 5-fluorouracil and actinomycin D for patients with refractory, high-risk gestational trophoblastic tumors.Cancer2002https://conductscience.org/library/papers/12209690PubMed
1819301571Management of gestational trophoblastic neoplasia with 5-fluorouracil and actinomycin D in northern China.J Reprod Med2009https://conductscience.org/library/papers/19301571PubMed
1917977170Efficacy of the FAEV regimen in the treatment of high-risk, drug-resistant gestational trophoblastic tumor.J Reprod Med2007https://conductscience.org/library/papers/17977170PubMed
2017086803Persistent gestational trophoblastic neoplasia after partial hydatidiform mole incidence and outcome.J Reprod Med2006https://conductscience.org/library/papers/17086803PubMed

See all 55 referencesDownload CSV of references

Cited by33

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 67 citations.

PMIDTitleJournalYearIn PapersSource
42740940Anti-Trop2-Guided Liposomes Restore Methotrexate Sensitivity in Chemoresistant Gestational Trophoblastic Neoplasia.Int J Nanomedicine2026https://conductscience.org/library/papers/42740940PubMed
42539462Treatment outcomes of gestational choriocarcinoma before and after EMA/CO introduction in Mongolia: a 15-year retrospective cohort study.Front Oncol2026https://conductscience.org/library/papers/42539462PubMed
42500174Impact of different EMA/CO treatment regimens in women with gestational trophoblastic neoplasia: brazilian multicenter retrospective cohort study.Rev Bras Ginecol Obstet2026https://conductscience.org/library/papers/42500174PubMed
42346253Gestational Trophoblastic Neoplasia Following Hydatidiform Mole and Non-Molar Pregnancy: Clinical and Prognostic Features from a 40-Year Cohort Study at a Reference Center in Southern Brazil.Curr Oncol2026https://conductscience.org/library/papers/42346253PubMed
42118332Targeting the GSK-3β/mTOR axis to overcome chemoresistance in gestational choriocarcinoma: molecular mechanisms and therapeutic opportunities.Cancer Chemother Pharmacol2026https://conductscience.org/library/papers/42118332PubMed
42047768Repurposing metformin for choriocarcinoma: targeting the AMPK/mTOR pathway.Naunyn Schmiedebergs Arch Pharmacol2026https://conductscience.org/library/papers/42047768PubMed
41859474Recurrent Post-Abortion Gestational Trophoblastic Neoplasia Successfully Treated with TP/TE: A Case Report.Int Med Case Rep J2026https://conductscience.org/library/papers/41859474PubMed
41277169Treatment Outcome and Associated Factors Among Women With Gestational Trophoblastic Neoplasia in Northwest Ethiopia: A Multi-Center Retrospective Cohort Study.Cancer Control2025https://conductscience.org/library/papers/41277169PubMed
40631439Diagnosis and management of gestational trophoblastic disease: 2025 update.Int J Gynaecol Obstet2025https://conductscience.org/library/papers/40631439PubMed
40031424Pembrolizumab in gestational trophoblastic neoplasia: Systematic review and meta-analysis with sub-group analysis of potential prognostic factors.Clinics (Sao Paulo)2025https://conductscience.org/library/papers/40031424PubMed
39052205Evolution of Treatment Strategies for Gestational Trophoblastic Neoplasia: Chemotherapy, Immunotherapy, and Molecular Targeted Therapy.Curr Treat Options Oncol2024https://conductscience.org/library/papers/39052205PubMed
39006993Chemo-resistant Gestational Trophoblastic Neoplasia and the Use of Immunotherapy: A Case Report and Review of Literature.Acta Med Philipp2024https://conductscience.org/library/papers/39006993PubMed
38803539Case report: Multidrug resistant gestational trophoblastic neoplasia: focus on failure of immunotherapy and success of high-dose chemotherapy.Front Oncol2024https://conductscience.org/library/papers/38803539PubMed
38681028Potential diagnostic challenges of intracerebral hemorrhage as an index presentation of metastatic choriocarcinoma: A case series.Clin Case Rep2024https://conductscience.org/library/papers/38681028PubMed
38074016Extragonadal Nongestational Choriocarcinoma With a Widespread Metastasis in a Young Female: A Case Report and Literature Analysis With a Focus on Unmet Needs.Cureus2023https://conductscience.org/library/papers/38074016PubMed
38023226The efficacy and safety of 5-fluorouracil/cisplatin/vincristine as a multi-agent chemotherapy regimen in gestational trophoblastic neoplasia.Front Oncol2023https://conductscience.org/library/papers/38023226PubMed
38008872Review of current literature on gestational trophoblastic neoplasia.J Egypt Natl Canc Inst2023https://conductscience.org/library/papers/38008872PubMed
37449086Challenges in treatment of gestational trophoblastic neoplasia in patients with MTHFR mutation: A case report.Gynecol Oncol Rep2023https://conductscience.org/library/papers/37449086PubMed
37425576A Metastatic Invasive Mole in a Perimenopausal Woman: A Rare Case.Cureus2023https://conductscience.org/library/papers/37425576PubMed
36648416Treatments and outcomes in high-risk gestational trophoblastic neoplasia: A systematic review and meta-analysis.BJOG2023https://conductscience.org/library/papers/36648416PubMed

See all 33 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/26760424

GET https://conductscience.org/api/papers/v1/26760424/references?page=2